An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Federal Reports
Report Date
Agency Reviewed / Investigated
Report Title
Type
Location
U.S. Agency for International Development
Closeout Financial Audit of the Bitter Cassava for Sweet Milk Program in Colombia, Managed by Cooperativa Colanta, Cooperative Agreement 72051419CA00006, January 1, 2024, to February 26, 2025
Examination of Society of Friends of the Edith Wolfson Medical Center's Compliance with Fixed Amount Award 72029422FA00001, Advanced Trauma Life Support Program in West Bank and Gaza, September 28, 2022, to December 31, 2023
This is the audit of the NEA's information technology systems security. Due to security concerns, this report is not published on the internet. You can obtain a copy of this report through a freedom of information act request at the following link: https://www.arts.gov/freedom-information-act-guide
The OIG Audit Division conducted an audit to assess the effectiveness of GPO’s inventory management and identify opportunities for cost savings and program improvements. Our audit focused on non-moving inventory.
The audit objective was to determine if the Defense Nuclear Facilities Safety Board (DNFSB) is effectively managing the Drug-Free Workplace Program.
The OIG found that the DNFSB effectively manages its Drug-Free Workplace Program to meet basic program objectives. However, the agency should update its Drug-Free Workplace Plan to align with current practices. The agency should also improve its internal and external communications to support more efficient program implementation and ensure that it achieves its goal of a drug-free workplace.
The report contains three recommendations to update the agency’s Drug-Free Workplace Plan, create implementation guidance, and improve communication.